Coronary heart disease and lipid-modifying treatment in African American patients.
about
Exposure to Persistent Organic Pollutants Increases Hospitalization Rates for Myocardial Infarction with Comorbid HypertensionHypertension-Related Morbidity and Mortality in African Americans?Why We Need to Do BetterEthnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users.Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study.Cholesterol is associated with the presence of a lipid core in carotid plaque of asymptomatic, young-to-middle-aged African Americans with and without HIV infection and cocaine use residing in inner-city Baltimore, Md., USA.Rosuvastatin: a risk-benefit assessment for intensive lipid lowering.Ethnic disparities in coronary heart disease management and pay for performance in the UK.Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk.Serum IL-6 levels are associated with significant coronary stenosis in cardiovascularly asymptomatic inner-city black adults in the US.Outcome comparison of African-American and Caucasian patients with severe aortic stenosis subjected to transcatheter aortic valve replacement: a single-center experience.Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.
P2860
Q28388341-0D2067EF-CCCA-4A6D-A3FD-46F50B936F42Q29399489-6A95B6CC-45CC-4A94-AF24-EC68FBA288B6Q34704611-C28122BF-5FE8-4AF1-8796-6DCA9F9101FBQ35056311-BA2BFDA0-EDB8-421E-B84A-7D8C090BFF9DQ35911343-900E4D86-414E-432B-B537-C3E43B4843DAQ35970440-60E9A672-1984-4E61-8B65-3630BA5040A3Q36249934-ADB067B5-5049-481B-AA3D-02056B901839Q37024532-B739FC3E-57F3-4BA6-9BD0-C57679872985Q37324416-3FB360CE-0E5F-4950-8FD6-CADABDC63077Q37331764-1C64756B-AF49-44AD-AAFD-9224E6532CDFQ42657780-E0A3114D-B825-4D4A-AB47-CD837DF159BFQ54941607-41E61CC8-88DB-4424-A33F-F0A44B9DA7AC
P2860
Coronary heart disease and lipid-modifying treatment in African American patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Coronary heart disease and lipid-modifying treatment in African American patients.
@ast
Coronary heart disease and lipid-modifying treatment in African American patients.
@en
type
label
Coronary heart disease and lipid-modifying treatment in African American patients.
@ast
Coronary heart disease and lipid-modifying treatment in African American patients.
@en
prefLabel
Coronary heart disease and lipid-modifying treatment in African American patients.
@ast
Coronary heart disease and lipid-modifying treatment in African American patients.
@en
P1476
Coronary heart disease and lipid-modifying treatment in African American patients.
@en
P2093
Keith C Ferdinand
P304
P356
10.1016/J.AHJ.2003.12.011
P407
P577
2004-05-01T00:00:00Z